Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus
Bronwyn M. Gunn, Richard Lu, Matthew D. Slein, et al.
Immunity (2021) Vol. 54, Iss. 4, pp. 815-828.e5
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Avidity in antibody effector functions and biotherapeutic drug design
Simone C. Oostindie, Greg A. Lazar, Janine Schuurman, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 10, pp. 715-735
Open Access | Times Cited: 139
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, et al.
Cell Reports (2021) Vol. 36, Iss. 4, pp. 109452-109452
Open Access | Times Cited: 119
Impact of structural modifications of IgG antibodies on effector functions
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 30
With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process
Silvia Crescioli, Shashidhar S. Jatiani, Leonard Moise
mAbs (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Improving Antibody Therapeutics by Manipulating the Fc Domain: Immunological and Structural Considerations
George Delidakis, Jin Eyun Kim, Katia George, et al.
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 249-274
Open Access | Times Cited: 47
Antibody effector functions are associated with protection from respiratory syncytial virus
Yannic C. Bartsch, Deniz Cizmeci, Jaewon Kang, et al.
Cell (2022) Vol. 185, Iss. 26, pp. 4873-4886.e10
Open Access | Times Cited: 38
Transforming vaccinology
Rino Rappuoli, Galit Alter, Bali Pulendran
Cell (2024) Vol. 187, Iss. 19, pp. 5171-5194
Closed Access | Times Cited: 10
The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice
Irfan Ullah, Guillaume Beaudoin-Bussières, Kelly Symmes, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100893-100893
Open Access | Times Cited: 29
Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine
Kyle L. O’Donnell, Friederike Feldmann, Benjamin Kaza, et al.
EBioMedicine (2023) Vol. 89, pp. 104463-104463
Open Access | Times Cited: 19
Combinatorial Fc modifications for complementary antibody functionality
Yannic C. Bartsch, Nicholas E. Webb, Eleanor Burgess, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults
Jinge Cao, Mengze Gan, Zhihao Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 262-262
Open Access
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates
Bronwyn M. Gunn, Ryan P. McNamara, Lianna Wood, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112402-112402
Open Access | Times Cited: 12
Single-dose HPV vaccine immunity: is there a role for non-neutralizing antibodies?
Chau Quang, Amy W. Chung, Ian H. Frazer, et al.
Trends in Immunology (2022) Vol. 43, Iss. 10, pp. 815-825
Closed Access | Times Cited: 19
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Ebene R. Haycroft, Samantha K. Davis, Pradhipa Ramanathan, et al.
Medical Microbiology and Immunology (2023) Vol. 212, Iss. 4, pp. 291-305
Open Access | Times Cited: 11
Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions
Florine E. M. Scholte, Ercan Karaaslan, Justin T. O’Neal, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Development and Structural Analysis of Antibody Therapeutics for Filoviruses
Xiaoying Yu, Erica Ollmann Saphire
Pathogens (2022) Vol. 11, Iss. 3, pp. 374-374
Open Access | Times Cited: 14
Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D
Matthew D. Slein, Iara M. Backes, Callaghan R. Garland, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101417-101417
Open Access | Times Cited: 2
Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis
Edward B. Irvine, Angel Nikolov, Mehak Zahoor Khan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 9, pp. 2369-2382
Open Access | Times Cited: 2
Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
Bronwyn M. Gunn, Shuangyi Bai
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 11, pp. 4328-4344
Open Access | Times Cited: 19
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Ruth A Purcell, Robert M. Theisen, Kelly B. Arnold, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
Andrew P. Hederman, Harini Natarajan, Leo Heyndríckx, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability
Angela Huttner, Selidji Todagbé Agnandji, Olivier Engler, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 12, pp. 1587-1594
Open Access | Times Cited: 7
Understanding Fc function for rational vaccine design against pathogens
Kathryn Bowman, Paulina Kapłonek, Ryan P. McNamara
mBio (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors
Dominic Paquin‐Proulx, Bronwyn M. Gunn, Aljawharah Alrubayyi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 17
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis
Jack Mellors, Tom Tipton, Sarah Katharina Fehling, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top